UNSPSC 51171813: Metopimazine

This classification denotes an antiemetic agent with the molecular formula C22H27N3O3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 238S75V9AV, chemically known as 4-piperidinecarboxamide, 1-(3-(2-(methylsulfonyl)-10h-phenothiazin-10-yl)propyl)- but generally known as metopimazine, which bears US NIH Compound Identifier 26388. European Medicines Agency schedules Metopimazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08908MIG.

UNSPSC 51171813 Metopimazine is a Commodity code capturing pharmaceutical products procured by state and local health and human services agencies, criminal justice departments, and cooperative purchasing alliances for clinical, correctional, and pharmacy benefit program use. Recent state and local solicitations under this code reflect demand for both direct pharmaceutical supply through wholesale distribution networks and specialized testing services where metopimazine or related compounds may factor into screening protocols. State and local issuing bodies include county community supervision and corrections departments, state health and human services commissions, and multistate cooperative purchasing organizations serving participating states and local government facilities.

Collin County Community Supervision and Corrections Department (Texas) issued RFP 2026-327 on July 9, 2026, for offender specimen collection and drug testing services due July 23, 2026, with an estimated contract value of $600,000 over two years plus optional renewals. The scope encompasses immunoassay screening with confirmatory testing (LC/MS/MS or GC/MS), electronic result reporting, and alternative methodologies including oral fluid and hair testing, covering approximately 25,031 annual tests at two collection sites in Plano and McKinney. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted RFP S1070000015802 on January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon through authorized wholesalers AmerisourceBergen, Cardinal Health, and Morris & Dickson. The Texas Health and Human Services Commission issued RFI HHS0017013 on March 27, 2026, to explore direct-to-manufacturer prescription fulfillment capabilities as a preliminary market intelligence phase preceding formal procurement, reflecting broader state interest in pharmacy benefit program modernization. Recent activity centers in Texas and the Upper Midwest with multistate cooperative purchasing components.